BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7672794)

  • 21. The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates.
    Nakopoulou L; Vourlakou C; Zervas A; Tzonou A; Gakiopoulou H; Dimopoulos MA
    Hum Pathol; 1998 Feb; 29(2):146-54. PubMed ID: 9490274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification.
    Mian C; Pennelli G; Barollo S; Cavedon E; Nacamulli D; Vianello F; Negro I; Pozza G; Boschin IM; Pelizzo MR; Rugge M; Mantero F; Girelli ME; Opocher G
    Eur J Endocrinol; 2011 Jun; 164(6):971-6. PubMed ID: 21422198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal Trends in the Presentation, Treatment, and Outcome of Medullary Thyroid Carcinoma: An Israeli Multicenter Study.
    Hirsch D; Twito O; Levy S; Bachar G; Robenshtok E; Gross DJ; Mazeh H; Benbassat C; Grozinsky-Glasberg S
    Thyroid; 2018 Mar; 28(3):369-376. PubMed ID: 29402183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antisurvivin oligonucleotides inhibit growth and induce apoptosis in human medullary thyroid carcinoma cells.
    Du ZX; Zhang HY; Gao DX; Wang HQ; Li YJ; Liu GL
    Exp Mol Med; 2006 Jun; 38(3):230-40. PubMed ID: 16819281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of cyclin-D1, bcl-2, and bax proteins, proliferating cell nuclear antigen (PCNA), and DNA-ploidy in squamous cell carcinoma of the oral cavity.
    Staibano S; Mignogna MD; Lo Muzio L; Di Alberti L; Di Natale E; Lucariello A; Mezza E; Bucci E; DeRosa G
    Hum Pathol; 1998 Nov; 29(11):1189-94. PubMed ID: 9824094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aggressive inherited and sporadic medullary thyroid carcinomas display similar oncogenic pathways.
    Ameur N; Lacroix L; Roucan S; Roux V; Broutin S; Talbot M; Dupuy C; Caillou B; Schlumberger M; Bidart JM
    Endocr Relat Cancer; 2009 Dec; 16(4):1261-72. PubMed ID: 19675075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of calcitonin immunoreactivity, amyloid staining, and flow cytometric DNA measurements in medullary thyroid carcinoma.
    Pyke CM; Hay ID; Goellner JR; Bergstralh EJ; van Heerden JA; Grant CS
    Surgery; 1991 Dec; 110(6):964-70; discussion 970-1. PubMed ID: 1745984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multivariate analysis of patients with medullary thyroid carcinoma. Prognostic significance and impact on treatment of clinical and pathologic variables.
    Dottorini ME; Assi A; Sironi M; Sangalli G; Spreafico G; Colombo L
    Cancer; 1996 Apr; 77(8):1556-65. PubMed ID: 8608543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.
    Apolinario RM; van der Valk P; de Jong JS; Deville W; van Ark-Otte J; Dingemans AM; van Mourik JC; Postmus PE; Pinedo HM; Giaccone G
    J Clin Oncol; 1997 Jun; 15(6):2456-66. PubMed ID: 9196162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
    J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term prognosis of medullary thyroid carcinoma.
    Rendl G; Manzl M; Hitzl W; Sungler P; Pirich C
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):497-505. PubMed ID: 18331612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma.
    Frank-Raue K; Machens A; Leidig-Bruckner G; Rondot S; Haag C; Schulze E; Lorenz A; Kreissl MC; Dralle H; Raue F; Schmid KW
    Thyroid; 2013 Mar; 23(3):294-300. PubMed ID: 22946486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medullary thyroid carcinoma experienced at Kanazawa University Hospital.
    Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Ohtake S; Nakamura S; Ishizaki T
    J Surg Oncol; 1996 Jan; 61(1):27-33. PubMed ID: 8544456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma.
    Drosten M; Hilken G; Böckmann M; Rödicker F; Mise N; Cranston AN; Dahmen U; Ponder BA; Pützer BM
    J Natl Cancer Inst; 2004 Aug; 96(16):1231-9. PubMed ID: 15316058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of thyroid transcription factor-1 (TTF-1) in human C cells and medullary thyroid carcinomas.
    Katoh R; Miyagi E; Nakamura N; Li X; Suzuki K; Kakudo K; Kobayashi M; Kawaoi A
    Hum Pathol; 2000 Mar; 31(3):386-93. PubMed ID: 10746684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polo-like kinase 1 expression in medullary carcinoma of the thyroid: its relationship with clinicopathological features.
    Ito Y; Nakamura Y; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Kakudo K; Miyauchi A
    Pathobiology; 2005; 72(4):186-90. PubMed ID: 16127294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.
    Barbet J; Campion L; Kraeber-Bodéré F; Chatal JF;
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6077-84. PubMed ID: 16091497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells.
    Starenki D; Hong SK; Lloyd RV; Park JI
    Oncogene; 2015 Aug; 34(35):4624-34. PubMed ID: 25435367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic and flow cytometric DNA study of medullary thyroid carcinoma.
    el-Naggar AK; Ordonez NG; McLemore D; Schultz P; Hickey RC; Samaan N
    Surgery; 1990 Dec; 108(6):981-5. PubMed ID: 2247844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in risk factors and Tumor Node Metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin.
    Karga H; Giagourta I; Papaioannou G; Doumouchtsis K; Polymeris A; Thanou S; Papamichael K; Zerva C
    Metabolism; 2011 May; 60(5):604-8. PubMed ID: 20667564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.